IL97808A - ) S, S, and S, R (-N-) 2- Hydroxycyclopentyl (-1-isopropyl-6-methyl argoline-8-carboxamides, their preparation and crude preparations - Google Patents

) S, S, and S, R (-N-) 2- Hydroxycyclopentyl (-1-isopropyl-6-methyl argoline-8-carboxamides, their preparation and crude preparations

Info

Publication number
IL97808A
IL97808A IL9780891A IL9780891A IL97808A IL 97808 A IL97808 A IL 97808A IL 9780891 A IL9780891 A IL 9780891A IL 9780891 A IL9780891 A IL 9780891A IL 97808 A IL97808 A IL 97808A
Authority
IL
Israel
Prior art keywords
hydroxycyclopentyl
methylergoline
isopropyl
compound
carboxamide
Prior art date
Application number
IL9780891A
Other languages
English (en)
Hebrew (he)
Other versions
IL97808A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL97808A0 publication Critical patent/IL97808A0/xx
Publication of IL97808A publication Critical patent/IL97808A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • H—ELECTRICITY
    • H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
    • H02J7/00—Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Power Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL9780891A 1990-04-11 1991-04-09 ) S, S, and S, R (-N-) 2- Hydroxycyclopentyl (-1-isopropyl-6-methyl argoline-8-carboxamides, their preparation and crude preparations IL97808A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/508,324 US5043341A (en) 1990-04-11 1990-04-11 N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides

Publications (2)

Publication Number Publication Date
IL97808A0 IL97808A0 (en) 1992-06-21
IL97808A true IL97808A (en) 1994-12-29

Family

ID=24022297

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9780891A IL97808A (en) 1990-04-11 1991-04-09 ) S, S, and S, R (-N-) 2- Hydroxycyclopentyl (-1-isopropyl-6-methyl argoline-8-carboxamides, their preparation and crude preparations

Country Status (24)

Country Link
US (1) US5043341A (zh)
EP (1) EP0452074B1 (zh)
JP (1) JPH04224578A (zh)
KR (1) KR0165124B1 (zh)
CN (1) CN1038937C (zh)
AT (1) ATE133414T1 (zh)
AU (1) AU634374B2 (zh)
CA (1) CA2040170A1 (zh)
CZ (1) CZ279745B6 (zh)
DE (1) DE69116590T2 (zh)
DK (1) DK0452074T3 (zh)
ES (1) ES2082923T3 (zh)
FI (1) FI96604C (zh)
GR (1) GR3019416T3 (zh)
HU (1) HU206113B (zh)
IE (1) IE72084B1 (zh)
IL (1) IL97808A (zh)
NO (1) NO177709C (zh)
NZ (1) NZ237753A (zh)
PT (1) PT97299B (zh)
RU (2) RU2002746C1 (zh)
TW (1) TW199859B (zh)
YU (1) YU47809B (zh)
ZA (1) ZA912628B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141944A (en) * 1990-04-11 1992-08-25 Eli Lilly And Company N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides
JPH0613145U (ja) * 1992-07-23 1994-02-18 日新電機株式会社 基板収納カセット
US5441961A (en) * 1992-08-27 1995-08-15 Eli Lilly And Company Substituted cyclo or bicycloalkylamides of (8β)-6-(substituted) ergolines
US5516943A (en) * 1993-09-14 1996-05-14 Sepracor, Inc. Process for preparing cyclic CIS-1-amino-2-alkanols
US5599985A (en) * 1993-09-14 1997-02-04 Sepracor, Inc. Optically pure 1-amido-2-indanols
JPH11503757A (ja) * 1995-04-18 1999-03-30 イーライ・リリー・アンド・カンパニー ５−ｈｔ▲下７▼レセプターにおいて生理学的および病理学的機能を生じるエルゴリン化合物の使用方法
US5880134A (en) * 1996-03-20 1999-03-09 Eli Lilly And Company Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT7 receptor
US6385208B1 (en) * 1998-06-02 2002-05-07 Cisco Technology, Inc. Serial media independent interface
WO2002100888A1 (en) * 2001-06-08 2002-12-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatin-dopamine chimeric analogs
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
JP2005220081A (ja) * 2004-02-06 2005-08-18 Toray Fine Chemicals Co Ltd ｃｉｓ−４−アミノ−１−ベンジル−３−ピロリジノールの製造方法およびピロリジン誘導体
EP2914276A4 (en) 2012-11-01 2016-07-13 Ipsen Pharma Sas SOMATOSTATIN ANALOGA AND DIMERE OUT
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997470A (en) * 1956-03-05 1961-08-22 Lilly Co Eli Lysergic acid amides
US4931447A (en) * 1987-06-15 1990-06-05 Eli Lilly And Company Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines
ZA884222B (en) * 1987-06-15 1990-02-28 Lilly Co Eli Cycloalkylamides of(8beta)-1-alkyl-6-(substituted)ergolines

Also Published As

Publication number Publication date
DK0452074T3 (da) 1996-02-19
FI96604B (fi) 1996-04-15
CZ279745B6 (cs) 1995-06-14
NO911398D0 (no) 1991-04-10
EP0452074A2 (en) 1991-10-16
FI911713A0 (fi) 1991-04-10
ATE133414T1 (de) 1996-02-15
US5043341A (en) 1991-08-27
KR0165124B1 (ko) 1999-03-20
CN1038937C (zh) 1998-07-01
RU2002746C1 (ru) 1993-11-15
ZA912628B (en) 1992-12-30
DE69116590D1 (de) 1996-03-07
DE69116590T2 (de) 1996-07-04
HU206113B (en) 1992-08-28
IE72084B1 (en) 1997-03-12
FI96604C (fi) 1996-07-25
ES2082923T3 (es) 1996-04-01
PT97299B (pt) 1998-08-31
CN1056496A (zh) 1991-11-27
GR3019416T3 (en) 1996-06-30
IL97808A0 (en) 1992-06-21
YU64691A (sh) 1994-01-20
NO177709C (no) 1995-11-08
NZ237753A (en) 1993-02-25
EP0452074A3 (en) 1992-03-04
CZ99091A3 (en) 1995-03-15
HUT56841A (en) 1991-10-28
AU7433791A (en) 1991-10-17
AU634374B2 (en) 1993-02-18
NO911398L (no) 1991-10-14
EP0452074B1 (en) 1996-01-24
JPH04224578A (ja) 1992-08-13
KR910018381A (ko) 1991-11-30
TW199859B (zh) 1993-02-11
FI911713A (fi) 1991-10-12
CA2040170A1 (en) 1991-10-12
YU47809B (sr) 1996-01-09
PT97299A (pt) 1992-01-31
NO177709B (no) 1995-07-31
RU2086551C1 (ru) 1997-08-10
IE911205A1 (en) 1991-10-23

Similar Documents

Publication Publication Date Title
EP0452074B1 (en) Ergoline-8-carboxamides for blocking 5HT receptors
EP0260555B1 (en) Benzo-fused cycloalkane and oxa- and thia-, cycloalkane trans-1,2-diamine derivatives
EP0296748B1 (en) Cycloalkylamides of (8beta)-1-alkyl-6-(substituted) ergolines
US5141944A (en) N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides
US4931447A (en) Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines
US4902691A (en) Heteroalkylamides of (8-β)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT2 receptors
EP0207696A1 (en) Dialkylaminotetrahydrobenzothiazoles and oxazoles
US5441961A (en) Substituted cyclo or bicycloalkylamides of (8β)-6-(substituted) ergolines
US5679674A (en) Optically active thiomorpholine derivatives
CA1302405C (en) Ergoline derivatives
NZ203252A (en) Ergot 5's-(2r-butyl)peptide alkaloid derivatives and pharmaceutical compositions
US4835159A (en) Ergoline esters useful as serotonin antagonists
JPS62249984A (ja) Ｄ−ノル−７−エルゴリン誘導体、その製法、薬剤組成物及び使用
US5010085A (en) Benzo-fused cycloalkane and oxa- and thia-cycloalkane trans-1,2-diamine derivatives
EP0411494A2 (en) Ergoline derivatives having dopaminergic activity
HU215594B (hu) Ciklohexadiénszármazékok, ezeket tartalmazó gyógyszerkészítmények, és eljárás a vegyületek előállítására

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees